bmi semaglutide for the treatment of overweight and obesity: A review - Bergmann - 2023 - Diabetes, Obesity and Metabolism What to Expect with Semaglutide

Studies indicate that small doses of DSIP can be effective for sleep regulation and may induce specific effects such as hypothermia

Acknowledgements Not applicable Funding Not applicable Ethics declarations Ethics approval and consent to participate Not applicable Consent for publication All authors agree to the publication of this article Competing interests The authors declare that there are no competing interests Additional information Publishers Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

The metabolic stress of rapid weight loss shifted the growth cycle months earlier

The North America GLP-1 receptor agonist market size is estimated at USD 13.8 billion in 2025 and is projected to reach approximately USD 38.4 billion by 2035, with a 10.8% CAGR from 2026 to 2035

The key consideration for seasonal residents is continuity